A new nationwide study from Siegfried & Jensen reveals that medication errors in the United States have reached alarming levels, with over 1.5 million Americans harmed every year and between 7,000 and 9,000 deaths annually linked directly to prescription mistakes. According to the study, 91% of all medication errors begin at the prescription stage, underscoring a critical, and preventable breakdown in patient safety across the healthcare system.
The analysis highlights an escalating patient-safety crisis that affects nearly every healthcare setting: hospitals, clinics, pharmacies, long-term care facilities, and private homes. Errors range from incorrect dosages and dangerous drug interactions to misprescribed high-risk medications. For millions of Americans, especially seniors and those managing multiple chronic conditions, the consequences can be catastrophic.
“These findings demonstrate a systemic failure in medication safety, impacting patients long before the drug ever reaches the pharmacy counter.” “Medication errors are not random accidents—they are predictable, preventable, and increasingly deadly.”
High-Risk Drug Categories Driving Fatal Mistakes
The study identifies the drug classes most frequently involved in U.S. medication errors:
Antibiotics – 20% of all medication errors
Antipsychotics – 19%
Central Nervous System (CNS) drugs – 16%
Cardiovascular medications – 15%
Opioids – 7%
These medications are widely prescribed, especially in hospitals and nursing homes, and often require precise dosing. Even small deviations can trigger seizures, organ failure, respiratory depression, allergic reactions, or death.
Who Is Most at Risk?
The study confirms that certain patient groups suffer the majority of prescription-related harm:
Adults 65+, who take more medications than any other age group
Polypharmacy patients, with 5+ prescriptions (30–38% higher risk)
Patients with mental illness, due to antipsychotic dosing sensitivity and high misuse rates
Children, especially in households where caregivers struggle with dosing and labeling clarity
Patients with chronic illnesses, such as diabetes, heart disease, and epilepsy
For older adults, medication errors frequently result in falls, delirium, drug toxicity, and emergency hospitalization.
The Most Common and Dangerous Types of Errors
Hospital and pharmacy data show:
33.6% of hospital medication errors involve administering a drug at the wrong time
24.1% involve incorrect dosages
17.2% involve the wrong medication entirely
Up to 25% involve LASA (look-alike/sound-alike) drug mix-ups
Pediatric home-use medication errors range from 2% to 33%
These mistakes often stem from illegible prescriptions, incomplete medical histories, communication breakdowns, or staff fatigue in understaffed facilities.
Pharmacy Oversight Failures
A separate review of 2024 pharmacist disciplinary actions reveals troubling patterns:
Texas: 127 adverse actions
Michigan: 114
Ohio: 106
California: 86
Nevada: 85
Florida: 72
Large populations, aging demographics, and high prescription volume appear to drive these disciplinary hot spots—along with staffing shortages. 80% of pharmacists report that understaffing directly contributed to a medication error in the past year.
The Economic Toll: A $77 Billion Problem
Medication errors cost the U.S. healthcare system:
$20+ billion yearly in medical care
Up to $77 billion when accounting for legal claims, readmissions, disability, and long-term care
$2.7–$5.1 billion per year from injectable drug errors alone
These numbers highlight the crushing financial burden of preventable mistakes.
A Call for Reform
The study concludes that medication errors constitute one of the most preventable forms of patient harm, yet remain one of the most widespread.
“From misprescription to mislabeling to understaffed facilities, these errors are avoidable at every stage.” “Patients deserve better safeguards, and negligent providers must be held accountable.”
Siegfried & Jensen urges policymakers to strengthen prescription protocols, expand pharmacist support, improve electronic prescribing systems, and ensure greater transparency in medication-error reporting.
